DLG4 and Alzheimer disease: Both iMGL‐ and hNSC‐derived EVs significantly reduced amyloid beta plaques, astrogliosis, and microglial activation, while restoring synaptophysin and postsynaptic density protein PSD‐95 to control levels in AD brains.